by Eric Christianson | May 22, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
I have many patients who take garlic supplements. One of the interactions I remember learning in pharmacy school is that garlic has the potential to increase the risk of bleeding when taken in combination with blood-thinning medications such as warfarin, DOACs,...
by Eric Christianson | May 19, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Thiazide diuretics are commonly are one of the most commonly used classes of antihypertensive agents. They carry many adverse effects. Some can be a nuisance while others can be more serious. In this blog post, I’ll run down the most common thiazide diuretic...
by Eric Christianson | Mar 3, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Blood pressure medications are commonly used in practice. You should know some of the major interactions with these medications. In this blog post, I will lay out my top 5 antihypertensive drug interactions and also share some information on how these interactions can...
by Eric Christianson | Jan 14, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Fenofibrate is a lipid-lowering medication indicated as monotherapy to treat primary hyperlipidemia, mixed dyslipidemia, and hypertriglyceridemia. While this medication has been around for many years, its formulation has continued to evolve. The different fenofibrate...
by Eric Christianson | Nov 29, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
In a discussion of statins and myalgia, it is always important to start with definitions. Muscle-related conditions associated with statins: Myalgia: Muscle pain. Defined as muscle symptoms without significant elevation of creatinine kinase (CK). Myopathy: Disease of...
by Eric Christianson | Nov 1, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Calcium channel blockers (CCBs) are split into two categories, dihydropyridines (DHP), such as amlodipine and nicardipine, and non-dihydropyridines (non-DHP), such as verapamil and diltiazem. While these two drug classes are both CCBs, there are some key similarities...
